This event took place on October 5, 2021. To view a replay of the webinar on demand, click here.
In this webinar, we discuss what we know about FDA regulation of cannabis and cannabis-derived products and look at trends in recent FDA enforcement over CBD products.
- Pathways for FDA authorization of cannabis and other cannabis-derived products, including CBD
- New Drugs
- New Dietary Ingredient Notification – Foods/Dietary Supplements
- New Animal Foods/Drugs
- What other cannabinoids are of commercial interest
- Other legal concerns around marketing cannabinoids
- Heather Hatcher, Ph.D., Regulatory Scientist, Womble Bond Dickinson (US) LLP
- Mark Vaders, Associate, Womble Bond Dickinson (US) LLP
- Nicole Brown, Chief Innovation Officer, Open Book Extracts
Click here to view more webinars on demand in our Seed to Sale Series.